Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients.

Koh HK, Chai ZT, Tay HW, Fook-Chong S, Choo KJL, Oh CC, Yeo YW, Koh HY, Pang SM, Lee HY.

J Am Acad Dermatol. 2019 Jun 10. pii: S0190-9622(19)30901-6. doi: 10.1016/j.jaad.2019.05.096. [Epub ahead of print]

PMID:
31195022
2.

Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures.

de Prost N, Ingen-Housz-Oro S, Duong Ta, Valeyrie-Allanore L, Legrand P, Wolkenstein P, Brochard L, Brun-Buisson C, Roujeau JC.

Medicine (Baltimore). 2010 Jan;89(1):28-36. doi: 10.1097/MD.0b013e3181ca4290.

3.

Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.

de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong TA, Chosidow O, Wolkenstein P, Brun-Buisson C, Maître B.

Crit Care Med. 2014 Jan;42(1):118-28. doi: 10.1097/CCM.0b013e31829eb94f.

PMID:
23989174
4.

Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Antoon JW, Goldman JL, Lee B, Schwartz A.

Pediatr Dermatol. 2018 Mar;35(2):182-187. doi: 10.1111/pde.13383. Epub 2018 Jan 9.

PMID:
29315761
5.

Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.

Nizamoglu M, Ward JA, Frew Q, Gerrish H, Martin N, Shaw A, Barnes D, Shelly O, Philp B, El-Muttardi N, Dziewulski P.

Burns. 2018 May;44(3):603-611. doi: 10.1016/j.burns.2017.09.015. Epub 2017 Oct 10.

PMID:
29029855
6.

Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).

Monteiro D, Egipto P, Barbosa J, Horta R, Amarante J, Silva P, Silva A.

Cutan Ocul Toxicol. 2017 Jun;36(2):163-168. doi: 10.1080/15569527.2016.1218501. Epub 2016 Aug 22.

PMID:
27487073
7.

Outcome of patients with toxic epidermal necrolysis syndrome revisited.

Ducic I, Shalom A, Rising W, Nagamoto K, Munster AM.

Plast Reconstr Surg. 2002 Sep 1;110(3):768-73.

PMID:
12172137
8.

Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States.

Hsu DY, Brieva J, Silverberg NB, Paller AS, Silverberg JI.

J Am Acad Dermatol. 2017 May;76(5):811-817.e4. doi: 10.1016/j.jaad.2016.12.024. Epub 2017 Mar 9.

9.

Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.

Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.

Am J Ophthalmol. 2010 Oct;150(4):505-510.e1. doi: 10.1016/j.ajo.2010.04.026. Epub 2010 Jul 8.

PMID:
20619392
10.

27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.

Weinand C, Xu W, Perbix W, Lefering R, Maegele M, Rathert M, Spilker G.

Burns. 2013 Nov;39(7):1449-55. doi: 10.1016/j.burns.2013.03.011. Epub 2013 May 20.

PMID:
23702222
11.

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.

Noe MH, Rosenbach M, Hubbard RA, Mostaghimi A, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Hughey LC, Kaffenberger BH, Kroshinsky D, Kwong BY, Miller DD, Musiek A, Ortega-Loayza AG, Sharon VR, Shinkai K, Summers EM, Wanat KA, Wetter DA, Worswick S, Margolis DJ, Gelfand JM, Micheletti RG.

JAMA Dermatol. 2019 Mar 6. doi: 10.1001/jamadermatol.2018.5605. [Epub ahead of print]

PMID:
30840032
12.

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T.

Clin Rev Allergy Immunol. 2018 Feb;54(1):147-176. doi: 10.1007/s12016-017-8654-z. Review.

PMID:
29188475
13.

Corticosteroids in Stevens-Johnson Syndrome/toxic epidermal necrolysis: current evidence and implications for future research.

Law EH, Leung M.

Ann Pharmacother. 2015 Mar;49(3):335-42. doi: 10.1177/1060028014560012. Epub 2014 Nov 18. Review.

PMID:
25406459
14.

Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.

Nguyen KD, Tran TN, Nguyen MT, Nguyen HA, Nguyen HA Jr, Vu DH, Nguyen VD, Bagheri H.

J Clin Pharm Ther. 2019 Feb;44(1):69-77. doi: 10.1111/jcpt.12754. Epub 2018 Aug 20.

PMID:
30129156
15.

The use of Biobrane® for wound coverage in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Rogers AD, Blackport E, Cartotto R.

Burns. 2017 Nov;43(7):1464-1472. doi: 10.1016/j.burns.2017.03.016. Epub 2017 May 16.

PMID:
28526303
16.

A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.

Lim VM, Do A, Berger TG, Nguyen AH, DeWeese J, Malone JD, Jordan K, Hom F, Tuffanelli L, Fillari P, Siu S, Grossman R.

Burns. 2016 Jun;42(4):836-43. doi: 10.1016/j.burns.2016.01.014. Epub 2016 Feb 1.

PMID:
26847613
17.

Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.

Papp A, Sikora S, Evans M, Song D, Kirchhof M, Miliszewski M, Dutz J.

Burns. 2018 Jun;44(4):807-815. doi: 10.1016/j.burns.2017.10.022. Epub 2018 Apr 4. Review.

PMID:
29627131
18.

Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.

Techasatian L, Panombualert S, Uppala R, Jetsrisuparb C.

World J Pediatr. 2017 Jun;13(3):255-260. doi: 10.1007/s12519-016-0057-3. Epub 2016 Sep 20.

PMID:
27650525
19.

Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.

Yamane Y, Matsukura S, Watanabe Y, Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z, Aihara M.

Allergol Int. 2016 Jan;65(1):74-81. doi: 10.1016/j.alit.2015.09.001. Epub 2015 Oct 9.

20.

Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults.

Hsu DY, Brieva J, Silverberg NB, Silverberg JI.

J Invest Dermatol. 2016 Jul;136(7):1387-1397. doi: 10.1016/j.jid.2016.03.023. Epub 2016 Mar 30.

Supplemental Content

Support Center